New NeoSickle installation
With this second installation, 80% of French samples are now analysed using the NeoSickle solution.
Biomaneo is proud to announce the installation of its sickle cell screening solution, NeoSickle, in the neonatal screening center of the Robert Debré University Hospital. With this second installation, after the one at the University Hospital of Lille, Biomaneo continues its progression in neonatal screening by installing its solution in the main French screening center for sickle cell disease. 80% of French samples are now analysed with the NeoSickle solution.